Aaron Wood

Aaron Wood

Auto-generated profile, based on publicly available information

Aaron Wood

Department of Electrical Engineering and Computer Science, University of Missouri, Columbia, Missouri, United States of America

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AWAaron Wood
Aaron Wood
SBSyed Barizuddin
Syed Barizuddin
CDCharles M Darr
Charles M Darr
CMCherian J Mathai
Cherian J Mathai
ABAlexey Ball
Alexey Ball
SGShubhra Gangopadhyay
Shubhra Gangopadhyay
Timely diagnosis of tuberculosis disease is critical for positive patient outcomes, yet potentially millions go undiagnosed or unreported each year. Sputum is widely used as the testing input, but limited by its complexity, heterogeneity, and sourcing problems. Finding methods to interrogate noninvasive, non-sputum clinical specimens is indispensable to improving access to tuberculosis diagnosis and care. In this work, economical plasmonic gratings were used to analyze tuberculosis biomarker lipoarabinomannan (LAM) from clinical urine samples by single molecule fluorescence assay (FLISA) and compared with gold standard sputum GeneXpert MTB/ RIF, culture, and reference ELISA testing results. In this study, twenty sputum and urine sample sets were selected retrospectively from a repository of HIV-negative patient samples collected before initiation of anti-tuberculosis therapy. GeneXpert MTB/RIF and culture testing of patient sputum confirmed the presence or absence of pulmonary tuberculosis while all patient urines were reference ELISA LAM-negative. Plasmonic gratings produced by low-cost soft lithography were bound with anti-LAM capture antibody, incubated with patient urine samples, and biotinylated detection antibody. Fluorescently labeled streptavidin revealed single molecule emission by epifluorescence microscope. Using a 1 fg/mL baseline for limit of detection, single molecule FLISA demonstrated good qualitative agreement with gold standard tests on 19 of 20 patients, including accurately predicting the gold-standard-negative patients, while one gold-standard-positive patient produced no observable LAM in urine. Single molecule FLISA by plasmonic grating demonstrated the ability to quantify tuberculosis LAM from complex urine samples of patients from a high endemic setting with negligible interference from the complex media itself. Moreover, agreement with patient diagnoses by gold standard testing suggests that single molecule FLISA could be used as a highly sensitive test to diagnose tuberculosis noninvasively.

12 May 2017 in ACS Omega
Verified
Journal Article
Open access
AWAaron Wood
Aaron Wood
CMCherian J. Mathai
Cherian J. Mathai
KGKeshab Gangopadhyay
Keshab Gangopadhyay
Sheila A. GrantSheila A. Grant
Sheila A. Grant
SGShubhra Gangopadhyay
Shubhra Gangopadhyay
The ability to image single molecules (SM) has been the dream of scientists for centuries, and because of the substantial recent advances in microscopy, individual fluorescent molecules can now be observed on a regular basis. However, the development of such imaging systems was not without dilemmas, such as the detection and separation of individual fluorescence emissions. One method to solve this problem utilized surface plasmon resonance (SPR) to enhance the emission intensity of SMs. Although enhancing the SM emission intensity has yielded promising results, this method does not fully utilize the unique plasmonic properties that could vastly improve the SM imaging capabilities. Here, we use SPR excitation as well as surface plasmon-coupled emission from a high-definition digital versatile disc grating structure to image and identify different fluorophores using the angular emission of individual molecules. Our results have important implications for research in multiplexed SM spectroscopy and SM fluorescence imaging.